Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol.

MLA

Mailman, Tiffany, et al. “Inhibition of Neuronal Cholesterol Biosynthesis with Lovastatin Leads to Impaired Synaptic Vesicle Release Even in the Presence of Lipoproteins or Geranylgeraniol.” Journal of Neurochemistry, vol. 119, no. 5, Dec. 2011, pp. 1002–15. EBSCOhost, https://doi.org/10.1111/j.1471-4159.2011.07474.x.

APA

Mailman, T., Hariharan, M., & Karten, B. (2011). Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol. Journal of Neurochemistry, 119(5), 1002–1015. https://doi.org/10.1111/j.1471-4159.2011.07474.x

Chicago

Mailman, Tiffany, Manoj Hariharan, and Barbara Karten. 2011. “Inhibition of Neuronal Cholesterol Biosynthesis with Lovastatin Leads to Impaired Synaptic Vesicle Release Even in the Presence of Lipoproteins or Geranylgeraniol.” Journal of Neurochemistry 119 (5): 1002–15. doi:10.1111/j.1471-4159.2011.07474.x.